Evaluation of hearing level in patients on long term aspirin therapy [version 2; peer review: 1 approved, 2 approved with reservations]

Introduction: Aspirin is a routinely prescribed drug, most notably for cardiovascular diseases, such as myocardial ischemia. This cross sectional, comparative study study aims to explore differences in hearing status between the cardiovascular disease patients on aspirin therapy and age matched cont...

Full description

Saved in:
Bibliographic Details
Published in:F1000 research 2017-01, Vol.6, p.445-445
Main Authors: Pokharel, Apar, Bhandary, Sangita
Format: Article
Language:English
Subjects:
Age groups
Aspirin
Biomarkers
Blood
Cardiovascular disease
Cardiovascular diseases
Copyright
Coronary artery disease
Diabetes
Diabetes mellitus
Drug dosages
Eardrum
Ears & hearing
Head injuries
Health risk assessment
Hearing loss
Heart
Heart diseases
Hypertension
Ischemia
Kidney diseases
Myocardial ischemia
Older people
Otolaryngology
Otology/Vestibular/Audiology
Patients
Population
Population studies
Public health
Tinnitus
Trauma
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Aspirin is a routinely prescribed drug, most notably for cardiovascular diseases, such as myocardial ischemia. This cross sectional, comparative study study aims to explore differences in hearing status between the cardiovascular disease patients on aspirin therapy and age matched controls. Methods: The study population consisted of 182 patients with heart disease taking long term aspirin (i.e., for more than one year). The control population consisted of 221 age matched controls who were not taking aspirin. Results: It was found that age of patient, not aspirin intake, was more important risk factor contributing to hearing loss.  Conclusions: When confounding factors like age of the patient, hypertension and diabetes were taken into account, aspirin in its antiplatelet dose was not found to be the cause of any audiological problems like tinnitus and hearing loss.
ISSN:2046-1402
2046-1402
DOI:10.12688/f1000research.11131.2